Because 63% of 27 adrenocortical carcinomas were HMGA2 positive while all 47 adrenocortical adenomas were HMGA2 negative in our study, HMGA2 IHC may possibly serve as a marker of malignancy in adrenocortical neoplasms. Here, HMGA2 is linked to adrenal cortex carcinoma.